This essential amino acid plays a vital role in breaking down fats in the liver and helps lower cholesterol levels
More than 7 in 10 people who have taken a prescription weight-loss medication report being satisfied, including 40% who say they are very satisfied
Weight-loss medications, including Wegovy (which was approved by the Food and Drug Administration (FDA) to treat adults with obesity in 2021) and similar medications like Ozempic (semaglutide) and Mounjaro (tirzepatide), have been tied to not only weight loss but also to a lowered risk of heart attack and stroke, making it seem like these are wonder drugs for a while, at least
Factors specific to retatrutide that might affect real-world outcomes include: The higher side effect rate could drive more discontinuations The heart rate increase might concern prescribers and lead to lower maintenance doses If pricing is higher than tirzepatide, cost barriers could limit access and adherence The more complex triple-agonist mechanism may require more careful monitoring, adding burden Conversely, the additional metabolic benefits (liver fat reduction, possibly better muscle preservation) might improve adherence by providing visible results beyond scale weight, motivating continued use
So the body is an ecosystem